Cocco E - Search Results

1

Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort study.

Frau J, Saccà F, Signori A, Baroncini D, Fenu G, Annovazzi P, Capobianco M, Signoriello E, Laroni A, La Gioia S, Sartori A, Maniscalco GT, Bonavita S, Clerico M, Russo CV, Gallo A, Lapucci C, Carotenuto A, Sormani MP, Cocco E; i-MuST study group. Frau J, et al. Among authors: cocco e. J Neurol. 2019 Oct;266(10):2440-2446. doi: 10.1007/s00415-019-09424-8. Epub 2019 Jun 17. J Neurol. 2019. PMID: 31209573

2

Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients.

Cocco E, Mancosu C, Fadda E, Murru MR, Costa G, Murru R, Marrosu MG. Cocco E, et al. J Neurol. 2002 Nov;249(11):1552-5. doi: 10.1007/s00415-002-0888-9. J Neurol. 2002. PMID: 12420096

3

PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients.

Cocco E, Murru MR, Melis C, Schirru L, Solla E, Lai M, Rolesu M, Marrosu MG. Cocco E, et al. J Neurol. 2004 Sep;251(9):1085-8. doi: 10.1007/s00415-004-0485-1. J Neurol. 2004. PMID: 15372250

4

Effect of dose and frequency of interferon beta-1a administration on clinical and magnetic resonance imaging parameters in relapsing-remitting multiple sclerosis.

Cocco E, Marchi P, Floris G, Mascia MG, Deriu M, Sirca A, Mamusa E, Lai M, Mura M, Mallarini G, Marrosu MG. Cocco E, et al. Funct Neurol. 2006 Jul-Sep;21(3):145-9. Funct Neurol. 2006. PMID: 17049133 Clinical Trial.

5

Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis.

Bergamaschi R, Rezzani C, Minguzzi S, Amato MP, Patti F, Marrosu MG, Bonavita S, Grasso MG, Ghezzi A, Rottoli M, Gasperini C, Restivo D, Maimone D, Rossi P, Stromillo ML, Montomoli C, Solaro C; DYMUS Group. Bergamaschi R, et al. Funct Neurol. 2009 Jul-Sep;24(3):159-62. Funct Neurol. 2009. PMID: 20018144

6

Managing MS in a changing treatment landscape.

Duddy M, Haghikia A, Cocco E, Eggers C, Drulovic J, Carmona O, Zéphir H, Gold R. Duddy M, et al. Among authors: cocco e. J Neurol. 2011 May;258(5):728-39. doi: 10.1007/s00415-011-6009-x. Epub 2011 Mar 25. J Neurol. 2011. PMID: 21437661 Review.

7

Epidemiology of multiple sclerosis in south-western Sardinia.

Cocco E, Sardu C, Massa R, Mamusa E, Musu L, Ferrigno P, Melis M, Montomoli C, Ferretti V, Coghe G, Fenu G, Frau J, Lorefice L, Carboni N, Contu P, Marrosu MG. Cocco E, et al. Mult Scler. 2011 Nov;17(11):1282-9. doi: 10.1177/1352458511408754. Epub 2011 Jun 7. Mult Scler. 2011. PMID: 21652610

8

HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia.

Cocco E, Sardu C, Pieroni E, Valentini M, Murru R, Costa G, Tranquilli S, Frau J, Coghe G, Carboni N, Floris M, Contu P, Marrosu MG. Cocco E, et al. PLoS One. 2012;7(4):e33972. doi: 10.1371/journal.pone.0033972. Epub 2012 Apr 11. PLoS One. 2012. PMID: 22509268 Free PMC article.

9

Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population.

Cocco E, Murru R, Costa G, Kumar A, Pieroni E, Melis C, Barberini L, Sardu C, Lorefice L, Fenu G, Frau J, Coghe G, Carboni N, Marrosu MG. Cocco E, et al. PLoS One. 2013 Apr 8;8(4):e59790. doi: 10.1371/journal.pone.0059790. Print 2013. PLoS One. 2013. PMID: 23593151 Free PMC article.

10

Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.

Melis M, Cocco E, Frau J, Lorefice L, Fenu G, Coghe G, Mura M, Marrosu MG. Melis M, et al. Among authors: cocco e. Neurol Sci. 2014 Mar;35(3):401-8. doi: 10.1007/s10072-013-1527-1. Epub 2013 Aug 30. Neurol Sci. 2014. PMID: 23990111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters